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Abstract
Background: Patients with coronary artery disease experience various barriers which impact their ability to optimally
manage their condition. Financial barriers may result in cost related non-adherence to medical therapies and
recommendations, impacting patient health outcomes. Patient experiences regarding financial barriers remain
poorly understood. Therefore, we used qualitative methods to explore the experience of financial barriers to
care among patients with heart disease.
Methods: We conducted a qualitative descriptive study of participants in Alberta, Canada with heart disease
(n = 13) who perceived financial barriers to care. We collected data using semi-structured face-to-face or
telephone interviews inquiring about patients experience of financial barriers and the strategies used to cope
with such barriers. Multiple analysts performed inductive thematic analysis and findings were bolstered by
member checking.
Results: The aspects of care to which participants perceived financial barriers included access to: medications,
cardiac rehabilitation and exercise, psychological support, transportation and parking. Some participants
demonstrated the ability to successfully self-advocate in order to effectively navigate within the healthcare
and social service systems.
Conclusion: Financial barriers impacted patients’ ability to self-manage their cardiovascular disease. Financial
barriers contributed to non-adherence to essential medical therapies and health recommendations, which may
lead to adverse patient outcomes. Given that it is such a key skill, enhancing patients’ self-advocacy and
navigation skills may assist in improving patient health outcomes.
Keywords: Coronary artery disease, Secondary prevention, Cardiac rehabilitation, Qualitative research, Financial
barriers
Background
Coronary artery disease (often referred to simply as
heart disease) is a leading cause of morbidity and
mortality globally [1]. While some people die follow-
ing an initial cardiac event, advances in thrombolytic
therapy [2] and percutaneous coronary intervention
[3], have enabled the vast majority to survive. Given
that more people are surviving their first cardiac
event, the importance of outpatient management of
chronic heart disease is ever growing. A mainstay of
heart disease management is the use of proven
cardio-protective medications [4, 5]. Another import-
ant facet in secondary prevention is engagement in a
structured physical activity program, often called car-
diac rehabilitation, which has been proven to reduce
risk of subsequent events [6].
Many patients with heart disease who should have ac-
cess to medical therapies do not receive the care that
might benefit them. Patients’ access to optimal therapies
is hindered by a myriad of barriers, such as physical bar-
riers (e.g., transportation, distance to services) [7],
system-level barriers (e.g., wait times [8, 9], access to
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services [10], and personal barriers (e.g., family responsi-
bilities, personal decision to not seek care) [8–10]. Financial
barriers are also commonly experienced among patients
with heart disease [11, 12]. Some patients may experience
financial barriers directly related to medical therapies (e.g.,
payments for medications and healthcare team visits) [4,
11, 13], while others experience indirect financial barriers
(e.g., employment difficulties, child care costs to allow
healthcare provider visits). Patients who experience
financial barriers may find themselves unable to adhere to
medical therapies [14, 15] or health behaviour recommen-
dations [16] due to direct or indirect costs. Rates of
cost-related non-adherence to medications are as high
as 10–12% [11, 15] and 23% [14] in Canada and the
United States, respectively. Not surprisingly, patient
outcomes are impacted by financial barriers and cost-
related non-adherence [13], resulting in lower quality
of life, poorer overall health status, and increased rate
of hospitalizations [11, 12].
As denoted by the Canada Health Act, the Canadian
publicly funded health system provides medically ne-
cessary hospital and physician services at no direct cost
to individual patients. Coverage of outpatient services,
including medications, is not universally provided. The
degree of coverage and eligibility criteria for these pub-
licly funded benefits varies substantially across prov-
inces [17]. While some heart disease patients may
qualify for public benefits, many patients need to pur-
chase private insurance plans to help cover these ex-
penses. Even those who are covered often need to pay
substantial premiums, deductibles or copayments to ac-
cess outpatient medications. While there is important
heterogeneity across provinces, our previous studies
have found that on average Canadian patients with
cardiovascular-related chronic conditions pay approxi-
mately $550 per year on drug expenditures, while
individuals with several comorbid conditions pay sub-
stantially more [11, 18].
Despite the prevalence of financial barriers and their
association with important health outcomes in patients
with heart disease, their nature and the experience of
having financial barriers remain poorly understood. This
is particularly concerning as healthcare providers may be
unaware of the struggles their patients encounter and
may be ill-prepared to help them overcome the root
causes of non-adherence to the therapies they prescribe.
Being unaware of patients’ individual circumstances and
how financial barriers are operationalized in their lives
may lead to victim blaming - or blaming non-adherence
on personal choices without understanding the con-
straining context of those ‘choices’ [19]. We thus sought
to examine in depth the experience of perceiving finan-




We undertook a qualitative descriptive analysis of a sub-
cohort of participants with coronary artery disease from
a broader grounded theory study [20, 21]. Qualitative
descriptive studies of this nature have been recognized
as important in the field of cardiovascular outcomes
research for understanding patient perspectives in com-
plex clinical care settings [22] and when used rigorously
can contribute to the advancement of health services
delivery models [23].
The purpose of the parent study was to develop a con-
ceptual framework for understanding how financial bar-
riers impact quality of life and clinical outcomes for
patients with cardiovascular-related chronic medical
conditions (heart disease, diabetes, stroke and hyperten-
sion). In this paper we include only the results from the
13 (of 34 total) participants who had self-reported hav-
ing coronary artery disease. We obtained approval from
our institution’s ethics review board and followed rec-
ommended procedures and protocols for consent and
data collection.
Sampling and data collection
Full details of sampling and data collection are reported
elsewhere [20]. We utilized purposive sampling [24] to
obtain a diverse group of participants representing strata
that had previously been demonstrated to be associated
with perceived financial barriers: age (<65 years/65+),
gender, indigenous status, and income [11]. Potential
participants were recruited passively via signage in phys-
ician offices and pharmacies, as well as actively through
research and clinical databases where participants had
pre-consented to being contacted for future research
studies. To be eligible for inclusion in this study, partici-
pants must have identified that they experienced a finan-
cial barrier in the past year by answering affirmatively to
the following question: In the past 12 months did you
have difficulty paying for services, equipment, medica-
tions for your chronic conditions? The broader study
aimed to recruit between 35 and 45 participants which
was expected to be sufficient to provide theoretical sat-
uration based on the fact that we were asking questions
on a reasonably focused topical area to a group of indi-
viduals with similar chronic conditions [24]. Consistent
with recommended practices in qualitative research, we
collected and analyzed data concurrently. This allowed
us to continue sampling and data collection until satur-
ation was achieved in the broader parent study. We pre-
determined that saturation would be assumed once three
consecutive interviews did not yield any new substantive
codes during initial analysis.
We also utilized negative and extreme case sampling to
enhance rigor. Extreme cases were individuals who claimed
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that their financial barrier resulted in a hospitalization in
the previous year, while negative cases were individuals
who endorsed having financial difficulties but who stated
that it didn’t have any meaningful impact on their life.
We collected data using semi-structured interviews
that focused on patients’ experiences of financial bar-
riers. Despite some inherent difficulties, our research
group has found over the years that telephone inter-
views using our protocols seem to be effective for gath-
ering this type of data [25]. Participants were therefore
offered the choice between on-site face-to-face inter-
view or interview by telephone. Interviews lasted 40–
90 min and they were digitally recorded. Recordings of
interviews were transcribed verbatim by a professional
transcriptionist.
Data analysis
Transcribed data were imported into NVivo 10 software
(QSR International: Doncaster, Australia) for analysis
purposes. We used an inductive thematic analysis strat-
egy informed by grounded theory coding techniques
[26, 27] All analyses were done in triplicate by three
experienced reviewers.
Following data analysis and the development of
preliminary findings, member checking (or validating
the study findings with a group study participants) [28]
was then accomplished by holding a focus group with
participants who had previously participated in inter-
views (n = 6). All study participants were invited to par-
ticipate in the member checking exercise and 6 of 13
participants with heart disease participated. We pre-
sented a summary of preliminary findings to participants
and received feedback and elaboration on these findings.
Data gathered during this focus group was used to con-
solidate and enhance the findings from the data collec-
tion phase of the study.
Results
The response rate for the broader parent study was 87%
(34/39). We interviewed 13 participants with heart disease,
9 men and 4 women (Table 1). The age range was from 47
to 75 years. Most participants identified that they had a
prior myocardial infarction (9/13). All participants had co-
morbid hypertension and/or diabetes. The median number
of medications was high: 9 for men and 8 for women. All
participants had supplemental health insurance to cover
the costs of medications. Most participants were married
(9/13), retired or unemployed (10/13), with reported house-
hold incomes < $40,000 Canadian dollars (10/13).
Despite having a universal single payer healthcare sys-
tem in Canada, we learned that heart disease patients
experience significant financial barriers to various as-
pects of care. These may hinder patients from accessing
crucial healthcare services, and potentially contribute to
worse health outcomes. The most prominently described
aspects of care to which participants perceived financial
barriers included access to: medications, cardiac rehabili-
tation and exercise, psychological support, and transpor-
tation/parking costs.





Age Mean (Years) 61.11 60.25
Range (Years) 47–71 55–75
Heart Disease Type Angina 3 1
Myocardial Infarction 6 3
Heart Disease Duration Mean (Years) 7 4
Range (Years) 1–20 1–10






Hypertension Yes 7 4
No 2 0
Diabetes Yes 6 3
No 3 1
Stroke Yes 0 2
No 9 2
Seen a medical specialist
in the previous year
Yes 8 3
No 1 1





Publicly Funded 4 2
Non-Group* 3 1





Education High School or less 3 3




Employment status Employed 2 1
Retired 5 1
Unemployed 2 2
Income category <$20,000 2 2
$20 – 40,000 4 2
>$40,000 3 0
*Non-Group coverage is that purchased privately by those not
otherwise insured
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Medication access
Medical therapies are critical to preventing future car-
diovascular events. Nearly all participants raised con-
cerns regarding the affordability of their medications.
Unfortunately, many participants reported that paying
for their required cardioprotective medications con-
sumed much of their budgets: “You kinda scrimp and
save and pull all your resources together and then the
cost of your medication just about gobbles that up.”
(Male, P2). Similarly, another participant stated about
her medications: “well look at how much money I would
save” (Female, P8).
Several participants stated that their financial barriers
resulted in cost-related medication non-adherence:
“The more you burden people with the medical costs the
worse off they are. They can’t concentrate on getting
better. Let’s face it, I’m sure it’s well known that people
don’t take their pills. They can’t afford to.” (Male, P3)
In the worst cases, some participants identified that
their cost-related non-adherence led to adverse clinical
outcomes: “I was off them for 3 months and I really
didn’t feel any difference. And then when you end up
in hospital and realize that maybe I should’ve been
taking them, kind of an eye opener but it’s an everyday
struggle.” (Male, P5)
Participants discussed various strategies to overcome
their financial barriers with respect to medications, in-
cluding: prioritizing some medications over other needs;
obtaining additional insurance; and the use of government
programs. Some participants ‘separated’ their medications
into essential and non-essential categories. For example
one participant said: “Well my medication, my diabetes,
the Metformin, I’ll continue buying that but the rest of it
will go by the wayside.” (Male, P2) Unfortunately, some
participants had to prioritize their medications over other
critical preventive health needs, such as healthy food:
“And that’s something that I have to do… if it’s medication
or food, well it’s gonna have to be the medication in order
to live and to get through this.” (Male, P5)
Despite the fact that all respondents had supplemental
health insurance, often sponsored by the government or
employers, only a small number of participants reported
being adequately insured. Many of those who had insur-
ance reported substantial out-of-pocket costs in the form
of copayments: “Part of my prescriptions are paid by my
company but still it’s an expense… [For] a lotta people
it’d be like $135, wow, that’s not very much but for me
it’s still a lotta money.” (Female, P4) Beyond copay-
ments, for those with unsponsored (non-group) insur-
ance, premiums may be an issue as well. Several
participants identified that their premiums cost more
than the benefits they provide. For example, a partici-
pant reported paying $2000 in premiums for $1800
worth of drug expenses.
Some participants identified that government income
support programs (which generally also include full
coverage for medications) helped them overcome financial
barriers: “If it wasn’t for me getting on [government pro-
gram] and getting help with medication… it was costing
me over $500 a month.” (Male, P2)
Cardiac rehabilitation and exercise
Physical activity, especially in the context of a structured
cardiac rehabilitation (CR) program is important to
minimize the risk of subsequent cardiovascular events. In
this study, participants universally described being referred
to a CR program following hospital discharge, and being
encouraged by healthcare providers to engage in physical
activity. Unfortunately, for many, participation in exercise
activities was hindered by the cost: “The downside of phys-
ical activity (is) I can’t afford to even do that.” (Female, P7)
In Alberta, there can be considerable direct fees for
CR patients, however these can be waived if the patient
states that they are unable to pay. Unfortunately, several
participants were unaware of the fee waiver program
and expressed concerns regarding the fees: “I was
shocked, like absolutely jaw dropping shock when I heard
that it was gonna be like the huge amount, that it was
gonna be” (Female, P4) and “It was never said that there’s
financial assistance if you need it.” (Male, P3) Another
participant was advised of the program, but stated: “The
fee…they said it could be like a sliding scale. But I assumed
that it couldn’t slide that far down for me.” (Female, P4)
One participant recounted the shame experienced from
the inability to pay: “I’ve never needed that kind of help
forever and then all of a sudden you’re saying I have to go
to this cardiac rehab, it’s a good program but I can’t afford
to pay for it. So yeah, that kinda, it hits home…a little
embarrassed I guess.” (Male, P3)
Other than the direct cost of the program, several par-
ticipants perceived financial barriers incurred due to the
required time away from work to participate in CR:
“When you do the simple math it’s like, ‘oh well we
want you here for 12 weeks, 2 times a week, 3 h a
day’… you lose an hour in the morning, you exercise
an hour, an hour to get back to work. Three hours a
day, 6 h a week, 12 weeks, 72 h. $25 an hour, plus the
$500 that they don’t cover in the exercise program.
That’s pretty close to $3,000 to me. I’m sorry but I’m
not doing their exercise program.” (Male, P5)
While the fee waiver program did not work for all
respondents, many were able to enrol in this program: “I
told them I didn’t have any money…I said there’s ab-
solutely no question that I can’t afford any of this and
they said ‘okay then’. They said ‘don’t worry about it,
we’ll waive it’”. (Male, P9)
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Several participants expressed that they were very
happy with the CR program they attended, but that they
experienced financial barriers to ongoing physical activ-
ity after having completed their 12-week CR program: “I
gotta buy a membership. Well I can’t afford member-
ships.” (Male, P10) Another respondent stated: “We have
got fees, you know, you have got charges to pay…about
$60 a month or something.” (Male, P11) and: “[My doc-
tor] wants me to do aquasizing. Well I can’t afford that…
it’s not in the cards to even do the pool. I would love to
but nope”. (Female P7)
Psychological support
It is well known that patients with heart disease are at
risk of significant mental and emotional health difficul-
ties. Many participants expressed that this was exacer-
bated by their inability to work due to their heart disease
and that the subsequent need to rely on others was taxing
on their self-esteem:
“When you work you’re whole, but when you get to the
point of having to depend on other people for your
income… It’s like you don’t become a whole person
anymore. You become pieces. And if you don’t have
that piece to help you through that life you can’t be
whole. It’s like you’re lost.” (Female, P7)
Social isolation resulting from financial barriers also
contributed to participants’ feeling depressed. Most par-
ticipants sacrificed social activities with the goal of sav-
ing money to spend on their healthcare requirements
(e.g., medication costs). For example, several participants
reported avoiding visiting the movie theatres, eating at
restaurants, and other recreational activities. A partici-
pant stated: “I can’t remember the last time I went out.
I’m in my apartment 7 days a week. So you do miss out
on interactions with other people…you have no social life
because you can’t afford it.” (Female, P4)
Some participants identified that their financial bar-
riers were not simply a cause of psychological distress,
but that these also hindered them from being able to ac-
cess necessary psychological supports. A participant
stated: “I really could’ve used more emotional support
from the system in terms of you know, ‘you’ve had a heart
attack, how do you feel? How do you feel about life? To
be able to discuss these issues of being confronted with
one’s own mortality.” (Male, P9) One participant expli-
citly stated: “So if I would’ve had some money to be able
to afford (it) I probably would’ve went and got some
professional help.” (Male, P3)
Transportation and parking
The incidental costs of seeking healthcare, such as trans-
portation and parking were a barrier that hindered some
participants’ access to medical care. Transportation re-
lated issues included: not being able to drive independ-
ently, having prohibitively long distances to healthcare
facilities, costs of gasoline, and the cost of parking at
hospitals and doctors’ offices.
Numerous participants described incurring indirect
costs due to driving long distances to healthcare facil-
ities, such as one participant who lived far from the re-
gional CR program: “You gotta run all the way to [the
city] and that’s ¾ of an hour at very best…one way, so I
mean you lose your day.” (Male, P6) Others described
that the cost of gasoline was prohibitive to them following
up as directed: “I had to pay my gas to drive into town
and everything. You gotta drive an hour, over an hour to
the [rehab centre] to go to cardiac rehab twice a week?
That is a huge financial burden on people” (Male, P3)
Finally, a commonly cited transportation-related finan-
cial barrier was related to the high cost of parking at
healthcare facilities. Many participants stated that they
had multiple specialist appointments to attend, and
these each required them to spend significantly for
transportation and parking:
It’s just a strain. This week we had Dr. [cardiologist] this
morning at 8:15 and I had an 11:15 at the [Hospital]
and was there ‘till quarter after 2. Tomorrow I have the
health nurse coming in and then I have to drive all the
way up to the [other hospital] to see the vascular
surgeon. (Female, P13)
Unfortunately, participants reported avoiding health-
care services (e.g., CR) because of transportation related
issues: “I started [CR] and it was going to be way too
much travel for me.” (Female, P4)
Navigation and advocacy
Clearly, when one is faced with financial constraints it is
important to be able to access resources that may be
available. Many participants acknowledged that one
main problem was difficulty navigating the healthcare
system and/or advocating for themselves to obtain the
information or assistance they required. The perceived
causes of these difficulties stemmed from a lack of un-
derstanding of the complexities of the healthcare system
or processes and an inability to communicate effectively
with healthcare providers.
For example, a participant who recently moved from
another province reported encountering difficulties iden-
tifying resources: “It’s been hard. I still don’t know all the
resources… everything is so split up here.” (Female, P7)
Being able to effectively communicate with healthcare
providers is a key navigation skill to overcome and deal
with an individual’s financial barriers. One participant felt
unwell for some time following his hospital discharge, he
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stated: “So after about a year I got a bit angry with the
cardiologist and said look, there’s a problem here, I want
you to check what it is and fix it. And he kinda looked at
me like who do you think you’re talking to.” (Male, P1)
This participant’s ability to advocate for himself led the
cardiologist to order further testing and adjust his medica-
tions accordingly.
By contrast, another participant expressed concerns
that he had multiple appointments with various pro-
viders, yet believed he was lacking appropriate attention
from any of them. He said:
“It’s frustrating not to be followed but at the same time
you gotta go to a doctor every week. I really struggle
and fight with that fact, it’s like, nobody’s bothering
to keep a check on any of this.” (Male, P5)
Other participants praised the healthcare providers
that were able to help them navigate through the health-
care and community support system: “I mean these guys
that I’m dealing with now with my heart problems… I’ve
got nothing bad to say about these guys. They bent over
backwards to get me back on [social programmes]. The
nurses are real good to deal with.” (Male, P12)
Clearly, there was a ‘skill set’ that some participants
demonstrated in navigating the healthcare system and ad-
vocating for their needs which enabled them to overcome
financial barriers which was lacking for numerous others.
Discussion
Given the growing numbers of patients and the known
societal costs associated with managing chronic heart
disease [11, 12], we undertook this qualitative descriptive
study to explore patients’ experiences with financial bar-
riers. Patients in this study identified that limited financial
resources reduced their ability to access medications, exer-
cise/CR and psychosocial support (all of which are known,
when not available, to increase the risk of future coronary
events) [29].
Financial barriers are commonly experienced among
patients with heart disease [11, 12]. A component of
heart disease management is the use of proven cardio-
protective medications; [4] greater than 90% of Canadian
patients with multiple chronic diseases take prescrip-
tion medications [5]. Our study participants raised con-
cerns regarding the affordability of their medications,
with several admitting to engaging in cost-related non-
adherence. Our findings are consistent with previous
studies that report cost-related medication non-adherence
is relatively common in this population [11, 15]. Some
participants identified their cost-related medication
non-adherence led to adverse clinical outcomes. This is
in keeping with prior studies that reported patients
who experience financial barriers encounter severe
clinical consequences more frequently (e.g., poorer health
status, and higher rates of all-cause re-hospitalization, car-
diac re-hospitalization, and mortality) [12, 30]. This is un-
surprising given that medication nonadherence has been
independently associated with these adverse outcomes
and higher costs of care [31, 32].
All study participants reported having health
insurance, yet they still encountered substantial out-
of-pocket costs (e.g., copayments and premiums). Our
finding is consistent with prior studies that insurance
coverage may not eradicate financial barriers because
patients may remain underinsured and faced with
substantial copayments [33]. Not surprisingly, patients
who are underinsured are more likely to engage in
cost-related medication nonadherence [15]. This is an
important finding as these barriers are potentially
modifiable given that insurance coverage is amenable
to being addressed by changes in public policy [34].
Cardiac rehabilitation has been proven to reduce risk
of subsequent cardiac events [6, 35]. Numerous partici-
pants in our study reported cost as a barrier to accessing
CR and post-CR exercise. Qualitative metasyntheses have
identified “accessibility” and “financial and work con-
straints” as barriers to CR attendance [36, 37]. Similarly,
several studies have identified low socioeconomic status
[38, 39] and cost [40] as barriers to CR participation.
Participants reported that mental and emotional health
difficulties were exacerbated by their inability to work
due to their heart disease. Furthermore, we identified that
social isolation resulting from financial barriers contrib-
uted to participants’ feeling depressed. Several authors
have reported that psychosocial risk factors, such as lack
of social support; social isolation; and depression, nega-
tively contribute to the prognosis and recovery from car-
diovascular disease [40, 41].
The incidental costs of seeking healthcare, such as
transportation and parking were a barrier that hindered
some participants’ access to medical care. For example,
participants reported avoiding healthcare services (e.g., CR)
because of transportation related issues. Transportation re-
lated issues included: not being able to drive independently,
having prohibitively long distances to healthcare facilities,
costs of gasoline, and the cost of parking at hospitals and
doctors’ offices. This finding has been commented on be-
fore by other authors who have identified that lack of
transportation [35, 38] and long distances to services [37]
may be barriers to CR participation.
Many participants experienced difficulty navigating the
healthcare system and/or advocating for themselves to
obtain the information or assistance they required. The
perceived causes of these difficulties stemmed from a
lack of understanding of the complexities of the health-
care system and an inability to effectively communicate
with healthcare providers. In contrast, some participants
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were able to effectively advocate for themselves and
communicate with healthcare providers. Being able to
effectively communicate with healthcare providers is a
key navigation skill to overcome and deal with financial
barriers. Clearly, some participants demonstrated a ‘skill
set, ’ specifically effective navigation and self-advocacy skills,
which enabled them to overcome financial barriers. Like-
wise in one study, participants who actively sought health
information were more likely to be involved in their health-
care [42]. Patients recognize the importance of self-
advocacy and have described self-advocating behaviour
[43], which may impact their ability to navigate within the
healthcare system. For example, when a patient is able to
share concerns regarding medication costs with a health-
care provider (e.g., pharmacist, physician, nurse, social
worker), information regarding support programs can be
offered by the provider and accessed by the patient [44].
The barrier to accessing these goods and services is there-
fore reduced. Healthcare providers may need to assist pa-
tients in developing self-advocacy skills [43, 45, 46], in an
effort to promote successful navigation.
There were both strengths and limitations to this
work. The people who participated in this study were
keenly interested in sharing their experiences about hav-
ing financial barriers to care. A major strength of this
work was that interviewers were well trained in qualita-
tive interviewing techniques. Thus, we believe that the
participants were candid and authentic with their re-
sponses to our questions. We also used rigorous qualita-
tive methods including member checking and multiple
analysts to improve the trustworthiness of our findings.
There were some limitations to this work as well. Be-
cause the interviews were undertaken at only one point
in time, we were unable to determine how the partici-
pants’ experiences may change over time. We acknow-
ledge that there may also be concerns about the
transferability of the study findings, given the small sam-
ple size from one geographic location. However, the
number of participants in this study was in keeping
with similar qualitative studies. Furthermore, it is im-
portant to note that low socioeconomic status is
strongly associated with coronary artery disease, there-
fore [47] many heart disease patients are at high risk
for having financial barriers. This significantly increases
the likelihood that our findings are representative of
and transferable to a large proportion of patients with
coronary disease across internationally. While conduct-
ing this analysis, it was our impression that we had
achieved some degree of saturation as similar themes
appeared in each transcript. However, while sampling
for the broader parent study continued until saturation
was reached, because this study is a secondary analysis
we cannot say with certainty that the heart disease co-
hort was fully saturated.
Conclusion
Patients with coronary artery disease face numerous bar-
riers that prohibit them from accessing the care they re-
quire for optimal secondary prevention. In this qualitative
study, we explored the facets of care to which financial bar-
riers are most likely to arise: medications, physical activity
(including cardiac rehabilitation), psychosocial supports
and transportation.
Self-advocacy and navigation skills were key factors
that some patients may use to overcome their financial
barriers. This is an important finding, as this is a poten-
tially modifiable factor which healthcare systems and in-
dividual healthcare providers can foster in patients to
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